024 Pharma, Inc.
CIK 0001307969
Revenue (TTM)
$1.08M
FY Oct 2017
Net Income (TTM)
−$240.39K
+572.9% YoY
FY Oct 2017
EPS Diluted (TTM)
$0.00
FY Oct 2017
Gross Margin
22.0%
FY Oct 2017
Operating Margin
-31.1%
FY Oct 2017
Net Margin
-22.3%
FY Oct 2017
Free Cash Flow (TTM)
$4.59K
FY Oct 2017
Cash
$160.05K
FY Oct 2017
Total Debt
—
FY Oct 2017
Shares Outstanding
336.35M sh
FY Oct 2017
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.